Exposure to maternal depression both during pregnancy and postpartum strongly associated with depressive symptoms in offspring
Women with schizophrenia also experience higher rates of delivery complications and neonatal complications versus women without mental disorders
5-unit increase in maternal late-pregnancy BMI linked to lower WASI performance IQ, NeuroTrax scores at age 6.5 years
No increased risk seen for ADHD, ASD, small for gestational age with prenatal antipsychotics exposure
At day 15, significantly greater reduction seen in depressive symptoms as measured by change in HAMD-17 score from baseline
No significant differences in language development seen at age 2 years for children born to mothers with epilepsy
Increase seen in visit rate from March 2020, with higher rate in April, which was sustained through November 2020
Concurrent tobacco use and minority race/ethnicity status further worsen outcomes with cannabis use disorder during pregnancy
Excessive information seeking doubles the odds of elevated posttraumatic stress and anxiety/depression